361 related articles for article (PubMed ID: 19322705)
1. Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation.
Yan SF; Yan SD; Ramasamy R; Schmidt AM
Ann Med; 2009; 41(6):408-22. PubMed ID: 19322705
[TBL] [Abstract][Full Text] [Related]
2. RAGE: a journey from the complications of diabetes to disorders of the nervous system - striking a fine balance between injury and repair.
Rong LL; Gooch C; Szabolcs M; Herold KC; Lalla E; Hays AP; Yan SF; Yan SS; Schmidt AM
Restor Neurol Neurosci; 2005; 23(5-6):355-65. PubMed ID: 16477098
[TBL] [Abstract][Full Text] [Related]
3. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications.
Bierhaus A; Nawroth PP
Diabetologia; 2009 Nov; 52(11):2251-63. PubMed ID: 19636529
[TBL] [Abstract][Full Text] [Related]
4. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.
Yan SF; Ramasamy R; Schmidt AM
J Mol Med (Berl); 2009 Mar; 87(3):235-47. PubMed ID: 19189073
[TBL] [Abstract][Full Text] [Related]
5. Unlocking the biology of RAGE in diabetic microvascular complications.
Manigrasso MB; Juranek J; Ramasamy R; Schmidt AM
Trends Endocrinol Metab; 2014 Jan; 25(1):15-22. PubMed ID: 24011512
[TBL] [Abstract][Full Text] [Related]
6. Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.
Leung SS; Forbes JM; Borg DJ
Curr Diab Rep; 2016 Oct; 16(10):100. PubMed ID: 27612847
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.
Yan SF; Ramasamy R; Schmidt AM
Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):285-93. PubMed ID: 18332897
[TBL] [Abstract][Full Text] [Related]
8. Targeting RAGE Signaling in Inflammatory Disease.
Hudson BI; Lippman ME
Annu Rev Med; 2018 Jan; 69():349-364. PubMed ID: 29106804
[TBL] [Abstract][Full Text] [Related]
9. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings.
Stern D; Yan SD; Yan SF; Schmidt AM
Adv Drug Deliv Rev; 2002 Dec; 54(12):1615-25. PubMed ID: 12453678
[TBL] [Abstract][Full Text] [Related]
10. Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response.
Clynes R; Moser B; Yan SF; Ramasamy R; Herold K; Schmidt AM
Curr Mol Med; 2007 Dec; 7(8):743-51. PubMed ID: 18331232
[TBL] [Abstract][Full Text] [Related]
11. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice.
Harja E; Bu DX; Hudson BI; Chang JS; Shen X; Hallam K; Kalea AZ; Lu Y; Rosario RH; Oruganti S; Nikolla Z; Belov D; Lalla E; Ramasamy R; Yan SF; Schmidt AM
J Clin Invest; 2008 Jan; 118(1):183-94. PubMed ID: 18079965
[TBL] [Abstract][Full Text] [Related]
12. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.
Stern DM; Yan SD; Yan SF; Schmidt AM
Ageing Res Rev; 2002 Feb; 1(1):1-15. PubMed ID: 12039445
[TBL] [Abstract][Full Text] [Related]
13. Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.
Gasparotto J; Girardi CS; Somensi N; Ribeiro CT; Moreira JCF; Michels M; Sonai B; Rocha M; Steckert AV; Barichello T; Quevedo J; Dal-Pizzol F; Gelain DP
J Biol Chem; 2018 Jan; 293(1):226-244. PubMed ID: 29127203
[TBL] [Abstract][Full Text] [Related]
14. Glycation & the RAGE axis: targeting signal transduction through DIAPH1.
Shekhtman A; Ramasamy R; Schmidt AM
Expert Rev Proteomics; 2017 Feb; 14(2):147-156. PubMed ID: 27967251
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
16. The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications.
Yan SF; Barile GR; D'Agati V; Du Yan S; Ramasamy R; Schmidt AM
Curr Diab Rep; 2007 Apr; 7(2):146-53. PubMed ID: 17425919
[TBL] [Abstract][Full Text] [Related]
17. Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease.
Schmidt AM; Stern DM
Front Biosci; 2001 Oct; 6():D1151-60. PubMed ID: 11578972
[TBL] [Abstract][Full Text] [Related]
18. Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes.
Wendt T; Bucciarelli L; Qu W; Lu Y; Yan SF; Stern DM; Schmidt AM
Curr Atheroscler Rep; 2002 May; 4(3):228-37. PubMed ID: 11931721
[TBL] [Abstract][Full Text] [Related]
19. Targeting receptors of advanced glycation end products (RAGE): Preventing diabetes induced cancer and diabetic complications.
Chhipa AS; Borse SP; Baksi R; Lalotra S; Nivsarkar M
Pathol Res Pract; 2019 Nov; 215(11):152643. PubMed ID: 31564569
[TBL] [Abstract][Full Text] [Related]
20. The biology of the receptor for advanced glycation end products and its ligands.
Schmidt AM; Yan SD; Yan SF; Stern DM
Biochim Biophys Acta; 2000 Dec; 1498(2-3):99-111. PubMed ID: 11108954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]